AI Science Tracker

ClickGen designs PARP1 inhibitors with measured nanomolar activity

Zhejiang University; Chengde Medical University; Hunan University; Macau University of Science and Technology; CarbonSilicon AI Technology Co., Ltd.; Macau Polytechnic University · 22 Nov 2024 · chemistry

Discovery

ClickGen designs PARP1 inhibitors with measured nanomolar activity

ClickGen combines reaction-based molecular generation, reinforcement learning and inpainting to generate synthesizable candidate structures. In a PARP1 case study, researchers selected and synthesized three generated lead molecules; two showed nanomolar PARP1 inhibition in vitro, with reported IC50 values of 19.24 ± 1.63 nM and 69.73 ± 14.57 nM. The two compounds also showed antiproliferative activity in several tested cancer cell lines and lower toxicity in the reported normal-cell assays than the most toxic lead compounds.

Technology: ClickGen deep-learning reaction-based molecular generator with reinforcement learning, Monte Carlo tree search and an inpainting generator

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: In a PARP1 case study, researchers selected and synthesized three generated lead molecules; two showed nanomolar PARP1 inhibition in vitro, with reported IC50 values of 19.24 ± 1.63 nM and 69.73 ± 14.57 nM.
  • Still unknown: Three selected molecules were synthesized and tested in vitro; the article reports two with nanomolar PARP1 inhibition. Cell-line antiproliferative and toxicity assays do not show tumor efficacy or safety in animals or people. The reported IC50 values are from triplicate measurements in the study. This record captures the PARP1 experimental result, not the paper’s model benchmark comparisons.
  • AI role: The system generated candidate molecules by assembling reaction-compatible synthons and using reinforcement learning/inpainting to guide novelty and binding-oriented generation. Researchers computationally filtered and selected compounds, synthesized three leads and tested them; PARP1 inhibition and cell effects were experimentally measured, not generated by the model.

Evidence sources: https://www.nature.com/articles/s41467-024-54456-y.pdf

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Citations: in the top 10% of works of the same type, year and subfield (OpenAlex work metrics, 45 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.

Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open in the full catalog for filters, charts and related discoveries.